非心源性缺血性卒中近期再发危险因素分析

doi:10.3969/j.issn.1673-5765.2018.07.006

摘要/Abstract

摘要：

目的探讨首发非心源性缺血性卒中且二级预防药物依从性好的患者近期再发的相关危险因素。

方法采用回顾性队列研究方法，纳入2014年1月-2016年4月首发非心源性缺血性卒中患者，根据随访1年是否有缺血性卒中再发分为再发组和对照组。对相关危险因素进行多因素回归分析。

结果共纳入258例非心源性缺血性卒中患者，27例（10.5%）1年内再次发生缺血性卒中。多因素回归分析显示：年龄[比值比（odds ratio，OR）1.66，95%可信区间（confidence interval，CI）1.28～2.13， P ＜0.001]、高血压病史（OR 3.23，95%CI 2.27～3.92，P ＜0.001）、糖尿病史（OR 2.23，95%CI 2.11～3.01，P＜0.001）、冠状动脉粥样硬化性心脏病（OR 1.36，95%CI 1.17～2.09，P =0.043）、慢性阻塞性肺病（OR 1.42，95%CI 1.11～2.09，P =0.031）、阻塞性睡眠呼吸暂停低通气综合征（OR 2.86， 95%CI 2.22～3.56，P＜0.001）、糖化血红蛋白（OR 2.67，95%CI 2.21～3.31，P＜0.001）、C反应蛋白（OR 1.32，95%CI 1.36～1.66，P =0.046）、同型半胱氨酸（OR 2.52，95%CI 2.05～3.55，P＜0.001）、出院时的Barthel指数（OR 2.10，95%CI 1.87～2.53，P＜0.001）等是缺血性卒中再发的危险因素。

结论高龄、高血压病、糖尿病、冠状动脉粥样硬化性心脏病、慢性阻塞性肺病、阻塞性睡眠呼吸暂停低通气综合征、日常生活能力下降、高糖化血红蛋白、高C反应蛋白、高同型半胱氨酸血症等是非心源性缺血性卒中1年再发的独立危险因素。

文章导读： 本研究通过多因素分析对二级预防依从性良好的非心源性缺血性卒中患者1年卒中复发的相关因素进行了分析，探讨影响近期卒中复发的危险因素，有助于指导二级预防。

关键词: 缺血性卒中; 卒中再发; 危险因素

Abstract:

Objective To explore the related risk factors of recent stroke recurrence in non-cardiac ischemic stroke patients with good compliance with secondary preventive medication. Methods Patients with non-cardiac ischemic stroke who were admitted into our hospital from January 2014 to April 2016 were included in the retrospective cohort study, and the recurrence group and the control group were divided according to the follow-up period of 1 year. Multi-factors regression analysis was used to analyze the related factors. Results A total of 258 patients with ischemic stroke were enrolled, of all patients, 27 ones (10.5%) had recurrent stroke. Multi-factors regression analysis showed that age [odds ratio (OR) 1.66, 95% confidence interval (CI) 1.28-2.13, P <0.001], hypertension (OR 3.23, 95%CI 2.27-3.92, P <0.001), diabetes (OR 2.23, 95%CI 2.11-3.01, P <0.001), coronary atherosclerotic heart disease (OR 1.36, 95%CI 1.17-2.09, P =0.043), chronic obstructive pulmonary disease (OR 1.42, 95%CI 1.11-2.09, P =0.031), obstructive sleep apnea hypopnea syndrome (OR 2.86, 95%CI 2.22-3.56, P <0.001), glycosylated hemoglobin (OR 2.67, 95%CI 2.21-3.31, P <0.001), C reactive protein (OR 1.32, 95%CI 1.36-1.66, P =0.046), homocysteine (OR 2.52, 95%CI 2.05-3.55, P <0.001) and activities of daily living (OR 2.10, 95%CI 1.87-2.53, P <0.001) were related to the recurrence of ischemic stroke. Conclusion Senior age, hypertension, diabetes, coronary atherosclerotic heart disease, chronic obstructive pulmonary disease, obstructive sleep apnea hypopnea syndrome, decreased daily living ability, high glycosylated hemoglobin, high C reactive protein, high homocysteine, are the independent risk factors for the recurrence of ischemic stroke.

Key words: Ischemic stroke; Recurrent stroke; Risk factors

杜庆霞, 王宇, 丁宁, 张蕴, 王勇. 非心源性缺血性卒中近期再发危险因素分析[J]. 中国卒中杂志, 2018, 13(07): 667-670.

DU Qing-Xia, WANG Yu, DING Ning, ZHANG Yun, WANG Yong. Risk Factors of Recent Stroke Recurrence in Non-cardiogenic Ischemic Stroke Patients[J]. Chinese Journal of Stroke, 2018, 13(07): 667-670.

参考文献

[1] SHOJIMA Y，UENO Y，TANAKA R，et al.

Predictors of mortality and the risk of recurrent

vascular events in ischemic stroke patients[J]. J

Neuro Sci，2017，381（11）：997.

[2] XU G，LIU X，WU W，et al. Recurrence after

ischemic stroke in Chinese patients：impact of

uncontrolled modifiable risk factors[J]. Cerebrovasc

Dis，2006，23（2-3）：117-120.

[3] 王新德. 各类脑血管疾病诊断要点[J]. 中华神经科杂

志，1996（6）：379-380.

[4] LEE J S，HONG J M，MOON G J，et al. A longterm

follow-up study of intravenous autologous

mesenchymal stem cell transplantation in patients

with ischemic stroke[J]. Stem Cells，2010，28（6）：

1099-1106.

[5] SULTER G，STEEN C，DE K J. Use of the Barthel

index and modified Rankin scale in acute stroke

trials[J]. Stroke，1999，30（8）：1538-1541.

[6] CÁMARA A L，ARCHE J，VIVAS P，et

al. Recurrence after a First- ever Ischemic

Stroke Development of a Clinical Prediction

Rule[J/OL]. 2013：264063. http：//dx.doi.

org/10.5171/2013.264063.

[7] KUWASHIRO T，SUGIMORI H，KAMOUCHI

M，et al. Lower levels of high-density lipoprotein

cholesterol on admission and a recurrence of

ischemic stroke：a 12-month follow-up of the

Fukuoka Stroke Registry[J]. J Stroke Cerebrovasc

Dis，2012，21（7）：561-568.

[8] OZA R，RUNDELL K，GARCELLANO

M. Recurrent Ischemic Stroke：Strategies for

Prevention[J]. Am Fam Physician，2017，96（7）：

436-440.

[9] ZHANG Y B，YIN Z，HAN X，et al. Association of

circulating high-sensitivity C-reactive protein with

late recurrence after ischemic stroke[J]. Neuroreport，

2017，28（10）：598.

[10] KUMRAL E，SARUHAN G，AKTERT D，et

al. Association of Hyperhomocysteinemia with

Stroke Recurrence after Initial Stroke[J]. J Stroke

Cerebrovasc Dis，2016，25（8）：2047-2054.

[11] 丁玲玲，胡文立. 慢性阻塞性肺疾病与缺血性卒中

[J]. 中国卒中杂志，2014，9（6）：529-533.

[12] LEKOUBOU A，OVBIAGELE B. Prevalence and

influence of chronic obstructive pulmonary disease

on stroke outcomes in hospitalized stroke patients[J/

OL]. Eneurologicalsci，2017，6：21-24. https：//doi.

org/10.1016/j.ensci.2016.11.007.

[13] DZIEWAS R，HUMPERT M，HOPMANN B，et al.

Increased prevalence of sleep apnea in patients with

recurring ischemic stroke compared with first stroke

victims[J]. J Neurol，2005，252（11）：1394-1398.

[14] 周正宏，于逢春，孟晓梅，等. 阻塞性睡眠呼吸暂停

低通气综合征与非心源性缺血性卒中复发关系探讨

[J]. 中国卒中杂志，2013，8（9）：697-702.

[15] KING S，CUELLAR N. Obstructive Sleep Apnea

as an Independent Stroke Risk Factor：A Review of

the Evidence，Stroke Prevention Guidelines，and

Implications for Neuroscience Nursing Practice[J]. J

Neurosci Nurs，2016，48（3）：133-142.